logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Sun Pharmaceutical Share Price

Sun Pharmaceutical Industries Ltd.

₹1,794.60

-0.80(-0.04%)

Invest in SUNPHARMA with up to 4.00x margin.

Trade with MTF
27th Mar 2026 | 3:28 PM
NSE : SUNPHARMA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Sun Pharmaceutical Performance

Price Movement

₹1794.60

₹1785.00

₹1819.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1794.60

₹1548.00

₹1851.20

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,819.00
Low₹1,785.00
Open at₹1,785.00
Prev Close₹1,795.40
Volumes29.75 L
Avg Price₹1,799.09
Lower Circuit₹1,615.90
Upper Circuit₹1,974.90

Historical Performance

3M High₹1,843.00
3M Low₹1,583.70
1 Yr High₹1,851.20
1 Yr Low₹1,548.00
3 Yr High₹1,960.35
3 Yr Low₹922.45
5 Yr High₹1,960.35
5 Yr Low₹587.25

Sun Pharmaceutical Fundamentals

Market Cap
Market Leader
4,30,344.70 Cr.
PE Ratio (TTM)
Above industry Median
39.40
Dividend Yield
Above industry Median
0.90
Net Profit TTM
5% decr over last year
10,915.27
Net Profit Growth
5% decr over last year
10,915.27
PEG Ratio
Negative PEG TTM
-8.70
ROE
0.6% incr over last year
15.13
Operating Revenue TTM
56,809.09
Operating Revenue Growth
10.1% incr over last year
Book Value
Above industry Median
5.30
MFI
MFI is mid-range
60.51
RSI
RSI is mid-range
56.77
EPS (TTM)
45.60
Debt to Equity
0.03
Face Value
1
Operating Profit Margin Qtr.
28
Operating Profit Qtr.
4,948.49
Net Profit Qtr.
3,368.81
Operating Revenue Qtr.
15,520.54
PB Ratio
5.30

Sun Pharmaceutical Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue5,687.774,548.115,601.967,185.746,191.81
Operating Expense3,929.173,364.523,710.814,196.284,488.34
Operating Profit1,758.601,183.591,891.152,989.461,703.47
Depreciation338.53336.30299.03291.96290.97
Interest244.17248.33223.29217.42215.96
Tax482.06107.53431.35611.6283.88
Net Profit705.44564.22753.532,000.461,181.05

SUNPHARMA Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,706 - ₹0

Target Price

₹2,000

Stop Loss

-

Target Date

23 Aug 26

Potential Returns

17.23 %

View Call ↗

Sun Pharmaceutical Technicals

Sun Pharmaceutical Industries Ltd. EMA & SMA

₹1794.60

-0.80 (-0.04%)

↗ Bullish Moving Average

16

↘ Bearish Moving Average

0

Day EMA5 ₹1774.9
Day EMA10 ₹1776.6
Day EMA12 ₹1776.3
Day EMA20 ₹1770.2
Day EMA26 ₹1764.1
Day EMA50 ₹1746.8
Day EMA100 ₹1729.8
Day EMA200 ₹1714.4

Sun Pharmaceutical Support and Resistance

Resistance

First Resistance₹1818.10
Second Resistance₹1840.80
Third Resistance₹1872.10

Support

First Support₹1764.10
Second Support₹1732.80
Third Support₹1710.10

Technical Indicators

Day RSI56.77
Day MFI60.51
Day ADX21.14
Day Commodity Channel Index19.00
William-45.29
Day MACD12.22
Day MACD Signal Line17.75
Day ATR35.93
Day ROC12510.07
Day ROC213.64

Sun Pharmaceutical Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter54.554.554.554.554.554.5
FII18181817.316.616.1
DII18.618.618.619.520.220.9
Public8.98.98.98.58.78.6

Sun Pharmaceutical Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day11.2 L19.63 L57.07%
Week17.05 L26.23 L65.00%
1 Month19.65 L29.65 L66.28%
6 Month16.12 L24.34 L66.26%

Sun Pharmaceutical SWOT Analysis

Strengths25
Weakness5
Opportunity2
Threats1

Benjamin Graham Value Screen

Price crossing above SMA20 today, and greater than SMA5

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

RSI indicating price strength

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Sun Pharmaceutical Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
05 Feb, 202611INTERIM05 Feb, 2026Equity Share
07 Jul, 20255.5FINAL07 Jul, 2025Equity Share
06 Feb, 202510.5INTERIM06 Feb, 2025Equity Share
12 Jul, 20245FINAL12 Jul, 2024Equity Share
09 Feb, 20248.5INTERIM09 Feb, 2024Equity Share
28 Jul, 20234FINAL28 Jul, 2023Equity Share
08 Feb, 20237.5INTERIM08 Feb, 2023Equity Share
19 Aug, 20223FINAL22 Aug, 2022Equity Share
09 Feb, 20227INTERIM10 Feb, 2022Equity Share
23 Aug, 20212FINALEquity Share

Sun Pharmaceutical Stock Comparison

Financials
Anthem Biosciences Ltd.
Sai Life Science Ltd.
Emcure Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Gland Pharma Ltd.
Laurus Labs Ltd.
Price (₹)₹676₹973.50₹1,659₹2,044₹1,707₹1,008
% Change4.67%-3.84%4.12%0.99%-0.20%-1.51%
Revenue TTM (₹ Cr)₹1,996.59₹2,169.86₹8,850.08₹13,914.08₹6,112.77₹6,721.63
Net Profit TTM (₹ Cr)₹484.66₹332.94₹869.92₹1,779.35₹847.18₹843.32
PE TTM79.0062.7036.0047.3033.5064.60
1 Year Return19.5533.3261.15-15.186.2264.09
ROCE26.8812.5120.8013.2711.4311.82

FAQ's on SUNPHARMA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy